Literature DB >> 24858640

Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis.

Jasenka Mazibrada1, Luisa Longo, Simona Vatrano, Susanna Cappia, Jessica Giorcelli, Monica Pentenero, Sergio Gandolfo, Marco Volante, Valentina dell'Oste, Irene Lo Cigno, Matteo Biolatti, Santo Landolfo, Mauro Papotti.   

Abstract

The aim of this study was to analyze protein and gene expression of HER2 in 224 head and neck precancerous and malignant lesions by immunohistochemistry and FISH analysis. In parallel, expression of pStat3, Sox2, IFI16 and p16, Ki67 was evaluated. Immunohistochemical analysis was assessed on formalin-fixed paraffin-embedded (FFPE) tissue specimens. A combined method for HPV detection consisting of p16 immunostaining and two PCR probes was applied. HER2 gene status was evaluated by FISH analysis. HPV DNA was detected in 24% of cases with predominant HPV16 genotype. HPV-positive lesions had higher HER2, pStat3 and within carcinoma group, and higher IFI16 expression compared to the HPV-negative group (Fig. 1A-B-C). A strong positive correlation between Sox2 and proliferative activity was observed, whereas IFI16 expression displayed a negative relationship with Sox2 and Ki67 activity. The most striking result was higher pStat3 expression in HPV-positive lesions and its strong positive correlation with IFI16 expression. The presence of HPV may induce upregulation of HER2/neu, pStat3 and IFI16. High levels and a strong positive correlation between pStat3 and IFI16 suggest their synergistic pro-apoptotic effects in HPV-positive lesions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24858640

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  15 in total

1.  A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.

Authors:  Elisa Pin; Steven Stratton; Claudio Belluco; Lance Liotta; Ray Nagle; K Alex Hodge; Jianghong Deng; Ting Dong; Elisa Baldelli; Emanuel Petricoin; Mariaelena Pierobon
Journal:  Mol Oncol       Date:  2016-10-14       Impact factor: 6.603

Review 2.  Manipulation of the innate immune response by human papillomaviruses.

Authors:  Shiyuan Hong; Laimonis A Laimins
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

3.  Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies.

Authors:  Netanya I Pollock; Lin Wang; Gerald Wallweber; William E Gooding; Weidong Huang; Ahmed Chenna; John Winslow; Malabika Sen; Kara A DeGrave; Hua Li; Yan Zeng; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2015-07-02       Impact factor: 12.531

4.  PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.

Authors:  Giuseppe Riva; Giancarlo Pecorari; Matteo Biolatti; Sara Pautasso; Irene Lo Cigno; Massimiliano Garzaro; Valentina Dell'Oste; Santo Landolfo
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

5.  Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx.

Authors:  Snjezana Dogan; Bin Xu; Sumit Middha; Chad M Vanderbilt; Anita S Bowman; Jocelyn Migliacci; Luc G T Morris; Venkatraman E Seshan; Ian Ganly
Journal:  Int J Cancer       Date:  2019-05-30       Impact factor: 7.396

Review 6.  Inflammasome control of viral infection.

Authors:  Christopher Lupfer; Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Curr Opin Virol       Date:  2015-03-12       Impact factor: 7.090

7.  Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients.

Authors:  Toni M Brand; Stefan Hartmann; Neil E Bhola; Noah D Peyser; Hua Li; Yan Zeng; Erin Isaacson Wechsler; Max V Ranall; Sourav Bandyopadhyay; Umamaheswar Duvvuri; Theresa M LaVallee; Richard C K Jordan; Daniel E Johnson; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2016-12-16       Impact factor: 12.531

Review 8.  Integrating Inflammasome Signaling in Sexually Transmitted Infections.

Authors:  Christopher Lupfer; Paras K Anand
Journal:  Trends Immunol       Date:  2016-08-31       Impact factor: 16.687

Review 9.  Inflammasomes in Inflammation-Induced Cancer.

Authors:  Chu Lin; Jun Zhang
Journal:  Front Immunol       Date:  2017-03-15       Impact factor: 7.561

Review 10.  Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review.

Authors:  Camila Hernandes; Ana Maria Soares Pereira; Patricia Severino
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.